Ask AI
Beyond Dopamine in Schizophrenia

CE / CME

Beyond Dopamine: Innovations in Schizophrenia Treatment and Addressing Unmet Needs

Psychologists: 1.00 APA CE Credit

Social Workers: 1.00 ASWB ACE CE Credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Released: June 12, 2025

Expiration: June 11, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How knowledgeable do you feel about the new mechanism of action, efficacy, and clinical use of schizophrenia therapeutic agents beyond D2 agonists?

2.

What is the role of trospium chloride in the xanomeline/ trospium combination for the treatment of schizophrenia?

3.

Which of the following represents how muscarinic agents directly address a significant unmet need in schizophrenia?